Does thrombolysis for pulmonary embolism reduce the risk of chronic complications?

Does thrombolysis for pulmonary embolism reduce the risk of chronic complications?

We assessed the efficacy of thrombolysis in avoiding long-term complications.

Notes of patients thrombolysed for PE in the 2-year period were reviewed. The initial CTPA and echocardiogram results before thrombolysis were compared to the results of follow up imaging repeated after 6 months.

Twenty-two patients were thrombolysed for PE. 14 patients had sub-massive PE and 8 patients had massive PE. The right ventricle (RV) was dilated on pre-thrombolysis echocardiogram in 16 patients.

On follow up echocardiography all patients with massive PE (6 studies) had a normal RV size, with pulmonary artery pressures (PAP) of 29mmHg. Follow up echocardiography of patients with submassive PE (13 studies) showed 11 patients with a normal RV, with PAP of 28 mmHg.

References

  1. Thomas DC, Limbrey M. Thrombolysis of acute PE patients reduces subsequent development of CTEPH. Thorax 2012; 67:Suppl 2 A125.
  2. Howard LS. Thrombolytic therapy for sub- massive pulmonary embolus? Pro viewpoint. Thorax 2014; 69(2): 103.
  3. Kline, J A, K E Nordenholz, et al. Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicentre doublebline, placebo controlled randomised trial. Journal of thrombosis and haemostasis: JTH 2014; no.4. doi:10.1111/jth.12521
  4. Sharma GV, Folland ED, Mcintyre KM, et al. Long term benefit of thrombolytic therapy in patients with pulmonary embolism. Vasc Med 2000; 5(2): 91–5.
  5. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003; 58(6):470–83.
  6. Sharifi M, Bay C, Skrocki L, et al. Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial). The American Journal of Cardiology 2013; 111(2): 273–77.
  7. Barco S, Russo M, Vicaut E, et al. Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Clinical Research in Cardiology 2018; 108(7): 772-8.

Request Permissions

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center’s (CCC) Marketplace website by clicking the button below:

Get Permission

Does thrombolysis for pulmonary embolism reduce the risk of chronic complications?

11th May 2021
PMID: 33749690
Authors Affiliations
Caroline Apsey Internal Medicine, University Hospital Lewisham, Lewisham and Greenwich National Health Service Trust, London
Muhammad Jawad Acute Internal Medicine, East Surrey Hospital, Surrey and Sussex Healthcare National Health Service Trust, Redhill
Martin Daschel Acute Internal Medicine, East Surrey Hospital, Surrey and Sussex Healthcare National Health Service Trust, Redhill
Daniel Woosey Acute Internal Medicine, East Surrey Hospital, Surrey and Sussex Healthcare National Health Service Trust, Redhill
Chis Limb Acute Internal Medicine, East Surrey Hospital, Surrey and Sussex Healthcare National Health Service Trust, Redhill
Mike Wilde Acute Internal Medicine, East Surrey Hospital, Surrey and Sussex Healthcare National Health Service Trust, Redhill

Does thrombolysis for pulmonary embolism reduce the risk of chronic complications?

Cite this article as:

Apsey C, Jawad M, Daschel M, Woosey D, Limb C, Wilde M. Does thrombolysis for pulmonary embolism reduce the risk of chronic complications? Acute Med. 2021;20(1):15-17. PMID: 33749690.

Does thrombolysis for pulmonary embolism reduce the risk of chronic complications?

Share this article

Click the icon of the social media platform on which you would like to share this article.


Shopping Basket
Scroll to Top